Logo of jester cap with thought bubble.

Image source: The Motley Fool.

DATE

Thursday, December 18, 2025 at 8:30 a.m. ET

CALL PARTICIPANTS

  • President and Chief Executive Officer — Paul Sternlieb
  • Chief Financial Officer — Darren Kozik

TAKEAWAYS

  • IT&S Product Sales Growth -- Product sales in the Industrial Tools & Services segment grew 4% organically, which management attributed to market share gains.
  • Product Orders -- The quarter saw strong growth in IT&S product order rates, which management cited as increasing confidence in the full-year outlook.
  • Gross Profit Margin -- Gross profit margin was 50.7%, consistent with recent quarters, as higher tariff-driven costs were offset by pricing and productivity actions.
  • Adjusted EBITDA -- Adjusted EBITDA was $32.4 million, representing an adjusted EBITDA margin of 22.4%.
  • Adjusted EPS -- Adjusted earnings per share were $0.36, down from $0.40, with a higher effective tax rate negatively impacting EPS by $0.02.
  • Net Debt Level -- Net debt was $49 million at quarter-end, resulting in a net debt to adjusted EBITDA ratio of 0.3.
  • Total Liquidity -- Liquidity, including cash and revolver availability, was $539 million.
  • Capital Allocation -- The company repurchased $15 million of stock while maintaining substantial liquidity for potential M&A activity.
  • Inventory Build -- Inventories were intentionally raised about 15% in response to order growth outpacing product revenue growth.
  • Capital Expenditures -- Decreased capital expenditures were noted, as the prior year included additional CapEx for new headquarters.
  • Full-Year Guidance Maintained -- Management reaffirmed guidance for organic revenue growth of 1%-4%, adjusted EBITDA growth of 6% at the midpoint, free cash flow of $100 million to $110 million, and adjusted EPS of $1.85 to $2.
  • Regional Performance -- EMEA product revenue grew 5%, while UK revenue declined 10% due to economic conditions and service market contraction.
  • Services Business -- The decline in service revenue, particularly in the UK, was attributed to soft oil & gas markets and the deliberate passing on of lower-margin projects.
  • Price Increase -- A new low single-digit price increase on product lines in the Americas and Europe was enacted in early December, with margin maintenance as a stated priority.
  • Innovation Investments -- Management is increasing R&D investments, aiming for nearly double the number of new product launches in fiscal 2026 compared to the five launches in 2025.
  • Commercial Initiatives -- Expansion of sales/distribution in India, Australia, and the Philippines, alongside e-commerce technology upgrades, is underway.
  • End Market Highlights -- Notable contract wins in US and international bridge/tunnel infrastructure and ongoing expansion in power generation and nuclear verticals were disclosed, with references to specific project awards.
  • Cortland Segment Growth -- The Cortland Biomedical business showed continued revenue growth and "very strong high margin" performance, generating $20 million in annual revenue, per management's comments.
  • Backlog Trend -- Backlog increased, as order growth exceeded revenue growth, especially in the HLT (Heavy Lifting Technology) segment; the DTA acquisition was cited as boosting cross-sell potential.
  • M&A Pipeline -- The company described a "considerable" increase in M&A opportunity flow, stating, "We are actively evaluating several opportunities."
  • Service Model Shift -- Transition from agent-based to direct service models in regions such as Algeria was cited as a means to capture higher margins and deepen customer relations.
  • Service Business Restructuring -- Management is "actively consolidating our service footprint," particularly in Europe, while making targeted growth investments.

Need a quote from a Motley Fool analyst? Email [email protected]

RISKS

  • Management cited a sharp decline in service revenue, particularly in the UK, due to "softness in the oil and gas market" and challenges in "backfilled all that with more business," indicating ongoing end-market headwinds for services.
  • Gross margin pressure from "higher tariff-driven costs" was noted, with management expecting a gradual easing later in the year.
  • Darren Kozik stated that Europe remains a "wild card" for fiscal year performance, which may reflect uncertainty in regional demand recovery.

SUMMARY

Enerpac Tool Group Corp. (EPAC 8.65%) reported 4% organic IT&S product sales growth and a 50.7% gross profit margin, with order growth outpacing revenues and an intentional 15% inventory build to support demand. Adjusted EBITDA reached $32.4 million (22.4% margin), while adjusted EPS declined to $0.36, affected by a higher tax rate. Management reaffirmed full-year guidance for 1%-4% organic revenue growth, 6% adjusted EBITDA growth at midpoint, and $100 million to $110 million in free cash flow. Capital returned to shareholders via a $15 million buyback was balanced by ample liquidity to pursue increased M&A activity reported this quarter. Strategic investments in innovation, sales expansion, and digital infrastructure are accelerating, with nearly double the new product launches targeted and notable contract wins cited in infrastructure and nuclear markets.

  • Management stated the most recent price increase in early December was limited to product lines in the Americas and Europe.
  • Paul Sternlieb noted, "we have seen, you know, our backlog tick up," attributing the growth to strong quarterly order activity, particularly in the HLT segment following the DTA acquisition.
  • Darren Kozik specified, "adjusted earnings per share was $0.36 compared with $0.40 in the year-ago period. A higher effective tax rate negatively impacted earnings by 2¢ per share."
  • Paul Sternlieb directly linked a service revenue decline in the UK to market dynamics, stating, "talked about in the past. But given the consolidation and softness in the oil and gas market, you know, we've not yet successfully backfilled all that with more business."
  • The company described M&A deal flow as having "definitely picked up," and indicated "very robust dialogue on any number of opportunities" currently underway.
  • Investments in the service business included shifting to direct models and new capital equipment, particularly in European leak sealing operations.
  • Management characterized Cortland Biomedical as a high-growth, high-margin business minimally reliant on corporate management resources.

INDUSTRY GLOSSARY

  • IT&S: Industrial Tools & Services; the primary operating segment of Enerpac encompassing hydraulic/mechanical tool production and related services.
  • HLT: Heavy Lifting Technology; a business line specializing in engineered solutions and capital equipment related to heavy lifting for infrastructure and industrial applications.
  • DTA: Dynamic Tool Alliance; an acquired company now integrated into Enerpac’s HLT segment, enhancing cross-selling opportunities.
  • Cortland Biomedical: Enerpac’s biomedical textile division, producing custom fibers for OEM medical device clients.
  • ECX: Enerpac Commercial Excellence; a global program to improve sales discipline and funnel management via process and technology upgrades.

Full Conference Call Transcript

Paul Sternlieb: Thanks, Travis, and good morning, everyone. For our 2026 results, were essentially as expected. And there were some favorable developments and encouraging trends. In our industrial tools and services segment, or IT&S, product sales grew a healthy 4% organically, which we believe is a reflection of our ongoing ability to gain market share and outperform our broader industrial peers. We saw strong IT&S product order growth for the quarter, increasing our confidence in the outlook for the year. And as I will talk about later, we continue to invest in the business to support our growth strategy.

With that, let me turn the call over to Darren who will provide more detail on our first quarter performance as well as geographic and end market trends. Darren?

Darren Kozik: Thanks, Paul. Within product revenue, particularly in the UK, turning to slide five, which shows our due to the timing. Describe as a wild card for fiscal 2026 given the underlying economic conditions declined 10%. Again, it's meaningful to separate product from services. In EMEA, product revenue grew 5%, continued strength from infrastructure and government spending and a solid performance in Southern year-over-year growth. In the second quarter and for the full fiscal year. Turning to Slide six. For 2026, gross profit margin of 50.7% was in line with our performance over the past few quarters. As expected, margins were affected by higher tariff-driven costs flowing through cost of goods sold.

However, we were able to successfully offset these on a dollar basis through pricing and productivity actions. We expect the margin pressure from tariffs to ease as we enter 2026. Additionally, we enjoyed a favorable mix shift within the portfolio, which was offset by lower service margins. On the selling, general, and administrative line, we were able to hold spending essentially flat year-over-year, offsetting the inflationary impact from compensation incremental spending and innovation with tight cost controls. As a result, adjusted EBITDA was $32.4 million, representing a margin of 22.4%. First quarter adjusted earnings per share was $0.36 compared with $0.40 in the year-ago period. A higher effective tax rate negatively impacted earnings by 2¢ per share.

Turning to the balance sheet shown on slide seven, Enerpac's position remains extremely strong. Net debt was $49 million at quarter-end, resulting in a net debt to adjusted EBITDA ratio of 0.3. Total liquidity, including availability under our revolver and cash on hand, was $539 million. The timing of receipts of payments in the quarter. Capital expenditures were also lower as the year-ago period included additional CapEx for our new headquarters. Finally, with our balanced capital allocation strategy, we repurchased $15 million of stock in the first quarter while we maintain ample dry powder for strategic M&A. Based on our performance in the first quarter and encouraging trends on the order front, we are maintaining our full-year fiscal 2026 guidance.

As shown on Slide eight, our expectations include organic revenue growth of 1% to 4%, and adjusted EBITDA growth of 6% at the midpoint. Free cash flow of $100 million to $110 million and earnings per share of $1.85 to $2. With that, let me turn it back to Paul.

Paul Sternlieb: Thanks, Darren. As I mentioned at the top of the call, we enjoy the pickup in order rates in the first quarter. A trend we achieved across all three geographic regions. Demand's been particularly healthy from the infrastructure, defense, and power generation markets. At the same time, we have a strong backlog and excellent pipeline in HLT. And with the global rollout of Enerpac commercial excellence or ECX, we are benefiting from more discipline and rigor in our sales process and funnel management. In light of the strong order flow, we built additional inventory in the first quarter to ensure that we have the right products in the right locations to meet customer demand on a timely basis.

As we've discussed, we are investing in our business to support Enerpac's growth strategy. As Darren mentioned, we are increasing spend on the innovation front, as we expect to deliver even more new product introductions in fiscal 2026. We are also investing in our commercial organization, expanding sales capabilities, coverage, and distribution in countries like India, Australia, and The Philippines. And we are enhancing our e-commerce capability with the implementation of a new technology platform that will improve the user experience and provide us with even more sophisticated marketing and analytical tools, all of which we expect to result in higher conversion rates.

The topic of innovation and growth was front and center during our recent annual global leadership conference, which is a gathering of Enerpac's roughly top 50 leaders held each year in Milwaukee. I was truly inspired by the excitement and energy amongst the team, and the work completed to further refine our growth strategy and update our strategic growth initiatives. Speaking of growth, two of the attractive verticals we mentioned over the past few quarters are power generation and infrastructure. In the former, the proliferation of AI data centers and growing demand for electricity, including a resurgence in nuclear energy, underscores the need for Enerpac's products and services.

As seen on slide nine, Enerpac provides a range of standard and specialized products and services that support the nuclear industry in multiple regions across all phases of building, operations and maintenance, inspection, refueling, and decommissioning. In addition to our standard industrial tools and services that many of you are familiar with, Enerpac sells a line of specialized tensioners under the BIOC name that have been the industry standard for refueling inspection for more than fifty years. The BIAOC lightweight, self-contained tensioner shown here is used to tighten reactor pressure vessel head studs. The SCT brings greater safety, reduces manpower, and shortens critical path time.

With decades of experience serving the industry, and sizable market share in specialized products, we believe we are well-positioned to capitalize on growth opportunities in nuclear. Another strong market we've addressed over the past few quarters is infrastructure, where we've enjoyed significant contract wins for bridge and tunnel projects both in The US and internationally. Recently, Enerpac was selected to design and build a bridge launching system for the Juneau Creek Bridge in Alaska, which can be seen on slide 10. Our custom hydraulic cylinders and computer controls will pull bridge segments into place. When completed, the bridge will be the highest crossing in the state at 285 feet and the longest single-span bridge built in Alaska since 1982.

As we continue to drive profitable growth at Enerpac, we believe we are well-positioned with multiple product lines in these key end markets to take full advantage of these secular trends and the opportunities in the market. Before we take questions, I would like to address a change on the investor relations front. Travis has accepted a position at another company and his last day with Enerpac is tomorrow. Travis has done an outstanding job building relationships and communicating Enerpac's story to investors. Moreover, he's been an invaluable resource internally, sharing intelligence and insight into the industry and capital markets.

I would like to take this opportunity to thank him for his many contributions and wish him all the best in his new role. We have a search underway for Travis's replacement. Until we fill the role, Darren will be the main point of contact for investors. With that, we'd be happy to take questions.

Eric: At this time, I would like to remind everyone, in order to ask a question, please press star followed by the number one on your telephone keypad. Your first question comes from the line of Will Gildea with CJS Securities. Please go ahead.

Will Gildea: Good morning.

Paul Sternlieb: Morning, Will. Thanks for taking our questions. You've talked for a number of quarters about efforts to improve profitability of the service business and investment ways that enable you to tap higher margin opportunities. What caused the sudden sharp decline in service revenue this quarter? And were you surprised by it?

Paul Sternlieb: Right. So, yeah, I think we were certainly disappointed on the top line performance in the service business this quarter. After a strong fiscal 2025 year growth actually for service. You know, the issue, as I referenced in the remarks, was largely driven by a contraction in The UK market. And as part of our ongoing initiatives to capture, you know, higher margin service business, we passed on lower margin projects as we've talked about in the past. But given the consolidation and softness in the oil and gas market, you know, we've not yet successfully backfilled all that with more business, particularly in The UK given some of the market conditions there.

I would say, as a reminder, our service business is a mix of rental and manpower. And overall, it is margin dilutive to Enerpac. We are actively consolidating our service footprint. We've already taken actions underway on that in Europe. While selectively continuing to make growth investments in the business. And I think it will take some time to work through the dynamics on the service side, but keep in mind that based on our reiterated guidance, we do anticipate growth and margin expansion in fiscal 2026.

Will Gildea: Thank you. That's helpful. And then I guess just a follow-up question on that. Can you add some more color to the changes you're making in services to capture higher value business? I know on the last call, you gave the example of transitioning Algeria from an agent-based model to a direct-based model. Can you talk about the reasoning behind that? And if an initiative like that is successful, how long of a runway do you have to make that change in other regions? Thank you.

Paul Sternlieb: Yeah. Thanks, Will. So I we're taking a number of initiatives. Some are commercial, like you referenced, where we're moving from an agent to a direct model. That's the direct model is more the norm for our business. The agent is more the exception. In the case of agents and moving to direct, we end up with, obviously, the direct customer relationship, which allows us to do more follow-on business, obviously, capture more margin as well. Just get a closer overall relationship with the customer. So we feel good about that model and the progress that we're making in transition to multiple there.

We're also investing in our service business both in field service capabilities, but also in capital equipment and tools. We've invested in the European market in our leak sealing business, for example, and some new capital equipment. That will allow us, we believe, to capture more growth opportunities and more market share in that service line and be able to respond to customers more quickly for their needs in that kind of service business. So we're making a number of improvements like that. We're continuing, as I talked about, to optimize footprint as well. Not only from a cost standpoint, but to be able to react quickly to customer needs.

Will Gildea: Thank you, and switching gears. Can you add some color on your pricing strategy heading into calendar year 2026? Should we be expecting an annual price increase at the beginning of the year?

Darren Kozik: Well, good question. So just as a reminder for everyone, we talked about in Q4. You know, going into the year, we saw about two points of benefit in price from the actions we took last year. You know, as we look at this year, you know, we will look to kind of remain obviously from a tariffs perspective and a price perspective. We're gonna make up for those on a dollar-for-dollar basis and hold our margin. So with that, we did you know, take a small low single-digit price increase in early December here. That will take some time to roll through the channel as we do have notice periods for that.

But we constantly look at price and productivity to keep our margin targets and margin high. Thank you very much.

Paul Sternlieb: Thank you.

Eric: Your next question comes from the line of Ross Sparenblek with William Blair. Please go ahead.

Ross Sparenblek: Hey. Good morning, gentlemen.

Paul Sternlieb: Good morning.

Darren Kozik: Morning, Ross.

Ross Sparenblek: When we think about your, you know, 2026 organic guide, a little bit of price, what is contributing there from new products? And kind of the cadence of your new product launches? Everything about the rest of the year or fiscal 2026?

Paul Sternlieb: Yeah. Ross, we're super excited by our innovation program. We highlighted that on the last Q4 earnings call. We launched, you may recall, five new products in fiscal 2025. We're pleased with the market acceptance. They continue to ramp commercially and globally. We also have a pretty ambitious innovation program and a set number of launches that we that we're targeting for this fiscal. Which are more than we launched in last fiscal. So, we're continuing to accelerate our innovation efforts. Part of it that is driven by additional investments we've made in innovation over the last few years.

In fact, if you look at our 10-K, actually, over the last three years, you'll see incremental R&D spend on a dollar basis, as a percent of revenue every single year. I think that's a good indication. Also, you know, some folks may have visited our new innovation lab here at our global headquarters in Downtown Milwaukee. That's another investment we've made to drive improvements in our innovation program and faster time to market. So, we're pretty excited by the innovation progress we've made. Excited about the commercialization of the ramp of those products, and excited about the products we're planning to launch here in fiscal 2026.

Ross Sparenblek: Okay. Well, when we think about kind of, you know, early days on this, you know, R&D flywheel, what is kind of the trajectory here as we think about, you know, the longer-term growth algo? I mean, are you trying to get a couple extra points of growth in new products? Are we targeting new adjacent TAMs, or is it just kinda upgrading and more defensive in the core portfolio?

Darren Kozik: Know, Ross, I think as we think about growth, I mean, you heard us reaffirm our guidance for this year kind of 1% to 4%. You know, I think as we think of the macro, you know, Europe was the wild card for us. As we look at the higher end of that range, that encompasses a little bit of price. Recovery in the market, and obviously successful launches of our new products. Beyond that, obviously, innovation and the product investments we're making as Paul referenced, really, increase in R&D over the last three years. We'll see that start to take off into the future.

Paul Sternlieb: Yeah. And Ross, I yeah. It's certainly part of the growth algorithm, you know, it is part of how we believe that you know, we are targeting to, perform or outperform our peer set. And we believe we've been able to do that successfully here. But I would also make the comment that, you know, obviously, we look very closely at our direct competitors and what they're doing from an innovation perspective. And we continue to firmly believe that we are outpacing not only investment spend, but just the pacing, intensity, and the level of new product launches relative to our competitive set.

So we never rest on our laurels, but we're pleased with the progress we've made, particularly relative to the competitive set.

Ross Sparenblek: Yeah. I can appreciate that. I mean, it looks like you guys are running around 2% of sales in your R&D spend. It has been ticking up slowly. I'm just trying to get a better sense of what your visibility looks like into your R&D funnel, like, how robust of opportunities you see today. Are we still kinda early days of planting the seeds? And, you know, buying the equipment and helping the guys, you know, get to the point where they're, you know, empowered to start building out that pipeline.

Paul Sternlieb: Yeah. So we do have a multiyear innovation funnel. So we're always looking several years out. We're working on, you know, now updating that funnel for another year out as we execute on products and projects for this year. And just a reminder, again, you know, we launched five new products in fiscal 2025. You know, our target is to nearly double that number of new product launches here in fiscal 2026. So I think you'll see us gain additional pace and acceleration. And just, again, you know, reflective of the investments and the focus and the new processes that we've put in place. So that all is part of our overall growth algorithm at the end of the day.

Ross Sparenblek: Okay. So we should anticipate a more measured pace of R&D growth going forward?

Paul Sternlieb: Yeah. I again, I think three and a percent of sales or five percent tomorrow. Yeah. No. I mean, I think you'll see a consistent ramp over prior years. You know? But, you know, we've talked about beating the market by several 100 basis points in terms of top-line growth at the end of the day. And, you know, part of that clearly will be driven by our innovation program.

Ross Sparenblek: Okay. I appreciate that. And if I can just add one more here. If I go back to last year, the backlog seemed pretty immaterial, but now we're speaking to confidence kind of these, secular growing, you know, project funnels. Any visibility there on sizing where the backlog kinda stands? Versus, like, a normalized basis and what's kind of underwriting that confidence?

Paul Sternlieb: Yeah. I mean, I'll make a few comments Darren may in as well. I think, you know, we do you know, we're not a very heavy backlog business, as you know. We tend to be more you know, book to bill or shorter cycle, and most of our products are what we would classify as more OpEx than by our customers. Although, we do have a capital equipment business in HLT, you know, inclusive of DTA. That has more backlog. And, those backlogs tend to be sort of six to twelve-month time frames.

You know, that said, I think we have seen, you know, our backlog tick up and that was driven by, you know, as we referenced on the remarks earlier, pretty strong order activity, and growth in overall orders in the quarter. And we were very pleased with that. And that order growth actually outpaced revenue growth in the quarter. So, again, giving us, you know, just more increasing confidence in our overall outlook for the year. Particularly as we as we go through the year. So I think all of that, you know, you know, just led us to maintain, you know, our current guidance for the full year.

Darren Kozik: Only thing I would add, Paul, is, you know, Ross, as we kinda look at the business, obviously, we acquired DTA last year. DTA being part of our HLT business now is really helping that. As those markets tick off, we now have more products for our customers. As we talked about in Q4, their cross-sell opportunity is huge. We're bullish on HLT for the year.

Ross Sparenblek: That makes sense. Alright. Well, thank you guys for the time. I'll pass it along.

Eric: Your next question comes from the line of Tom Hayes with ROTH Capital. Please go ahead.

Tom Hayes: Hey, good morning, guys. Thanks for taking my questions.

Darren Kozik: Good morning, Tom.

Paul Sternlieb: Hey, Tom.

Tom Hayes: Hey. Just wanted to go back to one of Will's questions on the pricing, Darren. Was that pricing act that you put in place in December across all product families and globally? And then kind of a related question on gross margin for the year. How are you thinking about the margin flowing through the balance of the three quarters? You guys have done a great job of offsetting the tariffs. Just wondering your thoughts on kind of puts and takes on the margin front for the balance of the year?

Darren Kozik: Sure, Tom. You know, I would say from the recent pricing those were in The Americas and in Europe. Now, you know, we did kinda release in this earnings a little bit more of a pie chart to give you a flavor for what our product business looks like. So just remember that low single-digit price increase is solely on product, it's not in the total portfolio. So when you factor that into the math, make sure you look at that aspect of it. I would say the second piece from a margin perspective you know, Q1 was where we thought it would be. Okay. Q2 will probably look more like Q1.

And then as we get into the second half of the year, some of those higher cost tariffs will work off their way through the system, so margin will improve as we enter the second half of the year.

Tom Hayes: Okay. Great. Appreciate that. I appreciate the color that on the product sales by region, but I'm not sure if you gave it by for APAC. Is that something you guys can share?

Paul Sternlieb: Yeah. I think it's it's actually in the slides page five. But in APAC, we actually saw growth in this revenue in standard products. We saw we did see a sharp decline in APAC on HLT. I mean, it's a small business, and HLT tends to be lumpy. So that just varies quite a bit from quarter to quarter.

Tom Hayes: Okay. Maybe just lastly, in respect to time, an area we don't talk about a lot, but you called it out on one of the early slides. It continues strong growth in Cortland. Just kind of remind us, a little bit about the business and kind of what's driving that strong growth.

Paul Sternlieb: Yeah. We continue to be really pleased with the progress the team is making at Cortland. As you recall, that's effectively our other segment. And that's Cortland Biomedical. So, you know, roughly a $20 million revenue business annually. Obviously, not connected to our core tools business, but it is a very strong, very solid high growth, and high margin business. And you know, it doesn't draw undue investment or sort of management time or attention. So it runs relatively independent. But that business is very long cycle, very sticky. They design and develop and manufacture, you know, custom biomedical textile fibers for specifically for particular medical devices for giving OEM customers.

So those are specked in and that those ultimate products that the customer has are obviously FDA qualified. So it's a very sticky business. Know, there is a lot of growth happening in that market. Cortland is exceptionally, we believe, well placed to support customers. We've won a number of new commercial opportunities, and you've seen that materialize in the ramp in revenue. So we continue to be quite bullish about the growth opportunities, the margin prospects, and we like the funnel of opportunities that we have there.

Tom Hayes: Appreciate the color. Thank you.

Paul Sternlieb: Mhmm. Thank you.

Eric: Your next question comes from the line of Steve Silver with Argus Research. Please go ahead.

Steve Silver: Thanks, operator, and thanks for taking my questions. And I'd like to offer my best wishes to Travis as well. So in the prepared remarks, you guys mentioned the pickup in order rates and you also mentioned building inventory heading into Q2. I'm curious just whether you can quantify at all the magnitude of the inventory ramp and maybe identify any key products beyond HLT?

Darren Kozik: No, great question. I mean, we think about inventory as we head into, you know, into the quarter, I mean, it's up about 15%. Okay? So we had a really strong Q4. As you think about Q1, our product sales were at 4%. Okay? So we were very pleased with that. With all those product sales coming through, know, we had to work because our order rates were stronger than our product revenue growth rates in the quarter.

Steve Silver: Great. And one more if I may. You guys have talked quite a bit in recent quarters about the balance sheet. Curious as to whether there's been any change in the M&A being in a very strong place to support strategic M&A. Funnel, if you will, just in terms of companies that are dealing with the macro issues that might be gravitating towards M&A at this time?

Paul Sternlieb: Yeah, sure, Steve. I would say I'm pretty encouraged there as well. I mean, I do think M&A activity overall in the market and here for Enerpac has picked up reasonably considerably in the last quarter or two. We are actively evaluating several opportunities so we're spending a lot of our time focused there at, you know, the pace and quantity of deal flow has definitely picked up. We're having very robust dialogue on any number of opportunities. So I feel, you know, more positive and optimistic around that, the same time, I would say, you know, we remain extremely disciplined.

As always, we will certainly not overplay overpay and, you know, our focus ultimately is, of course, on creating value for Enerpac shareholders at the end of the day.

Steve Silver: Fair enough. Thanks again, and happy holidays to the entire team.

Paul Sternlieb: Thank you. Thank you. Thanks very much. Happy holidays.

Eric: As a reminder, if you would like to ask a question, there are no further questions at this time. I will now turn the call back over to Paul Sternlieb for closing remarks. Please go ahead.

Paul Sternlieb: Okay. Well, thanks again for joining us this morning. We will be participating in the CJS new ideas for the New Year virtual conference on January 14, and the annual Roth conference in Laguna Niguel, California in late March. Thank you, and to all our team members around the world, customers, partners, and shareholders, best wishes for a wonderful holiday season, and a happy New Year.

Eric: Ladies and gentlemen, this concludes today's call. Thank you all for joining, and you may now disconnect.